DOV
55
14
EFX
68
2
JBHT
40
14
EMN
42
2
HOG
38
4
ADP
79
2
GRMN
59
3
VIX
27
-8
CPB
44
2
KSS
37
3
ALLE
39
-2
KO
57
2
KHC
27
3
EOG
46
14
CAT
48
2
CVX
32
4
COP
36
5
AXP
73
4
GILD
64
2
AIV
43
2
DOV
55
14
EFX
68
2
JBHT
40
14
EMN
42
2
HOG
38
4
ADP
79
2
GRMN
59
3
VIX
27
-8
CPB
44
2
KSS
37
3
ALLE
39
-2
KO
57
2
KHC
27
3
EOG
46
14
CAT
48
2
CVX
32
4
COP
36
5
AXP
73
4
GILD
64
2
AIV
43
2
Financhill
Back

Takeda Pharmaceutical 10K Form

Sell
18

TKPHF
Takeda Pharmaceutical

Last Price:
$27.60
Seasonality Move:
0.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TKPHF News And Ratings

See the #1 stock for the next 7 days that we like better than TKPHF

TKPHF Financial Statistics

Sales & Book Value

Annual Sales: $30.1B
Cash Flow: $854.8M
Price / Cash Flow: 10.14
Annual Sales: $29.45
Price / Book: 0.94

Profitability

EPS (TTM): 0.43640
Net Income (TTM): $710.2M
Gross Margin: $19.7B
Return on Equity: 1.49%
Return on Assets: 0.72%

Takeda Pharmaceutical Earnings Forecast

Key Takeda Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 26 years for TKPHF is 65.51%.
  • The Selling, General & Administrative Expenses for TKPHF have been equal to 24.11% of Gross Profit Margin.
  • The Research & Development expenses have been 15.94% of Revenue.
  • The Interest Expense is 194.63% of Operating Income.
  • The Net Earning history of TKPHF is 2.36% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 15 years.

Takeda Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TKPHF
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.65
Current Ratio: 1.01
Quick Ratio: 0.45

Price-to-Earnings

Trailing P/E Ratio: 63.51
Forward P/E Ratio: 0

TKPHF Technical Analysis vs Fundamental Analysis

Sell
18
Takeda Pharmaceutical (TKPHF) is a Sell

Is Takeda Pharmaceutical a Buy or a Sell?